Mankind Pharma Ltd Cash Flow Reinvestment Rate
Mankind Pharma Ltd cash flow reinvestment rate. Mankind Pharma Ltd (MANKIND) has a Cash Flow Reinvestment Rate of 0.17x as of September 2025, reinvesting Rs2.71 Billion (capex Rs2.71 Billion ) from operating cash flow of Rs16.37 Billion. Explore Mankind Pharma Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Mankind Pharma Ltd (2019–2026)
Cash flow reinvestment rate of Mankind Pharma Ltd from 2019 to 2026. Historical reinvestment intensity for Mankind Pharma Ltd across 8 annual periods. Explore MANKIND capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Mankind Pharma Ltd Cash Flow Reinvestment Rate by Year (2019–2026)
Mankind Pharma Ltd cash flow reinvestment rate by year from 2019 to 2026. Year-by-year capital reinvestment analysis for Mankind Pharma Ltd. For the full cash flow conversion analysis, see Mankind Pharma Ltd (MANKIND) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.44x | Rs10.98 Billion | Rs25.16 Billion | Rs6.26 Billion | ▼ -22.3% |
| 2025 | 0.56x | Rs13.56 Billion | Rs24.13 Billion | Rs4.61 Billion | ▼ -43.2% |
| 2024 | 0.99x | Rs21.29 Billion | Rs21.52 Billion | Rs3.82 Billion | ▲ +76.2% |
| 2023 | 0.56x | Rs10.17 Billion | Rs18.13 Billion | Rs8.32 Billion | ▼ -86.1% |
| 2022 | 4.04x | Rs37.15 Billion | Rs9.20 Billion | Rs23.46 Billion | ▲ +199.3% |
| 2021 | 1.35x | Rs15.35 Billion | Rs11.37 Billion | Rs3.12 Billion | ▲ +116.4% |
| 2020 | 0.62x | Rs6.67 Billion | Rs10.70 Billion | Rs2.28 Billion | ▲ +25.8% |
| 2019 | 0.50x | Rs2.98 Billion | Rs6.00 Billion | Rs2.98 Billion | — |